Endocyte, Inc. to Present at the Future Leaders in the Biotech Industry Conference

Published: Apr 01, 2013

WEST LAFAYETTE, Ind., April 1, 2013 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted small molecule drug conjugates (SMDCs) and companion imaging diagnostics for personalized therapy in cancer and other serious diseases, today announced that Ron Ellis, president and CEO of Endocyte, will present at the Future Leaders in the Biotech Industry Conference on Friday, April 5, at 2:30 p.m. EDT. The conference is being held at the Millenium Broadway Hotel & Conference Center, New York.

Back to news